ARTICLE | Company News
CytomX, Bristol-Myers deal
January 25, 2016 8:00 AM UTC
CytomX received a $10 million milestone payment from Bristol-Myers Squibb under a 2014 deal granting BMS exclusive, worldwide rights to develop and commercialize probody-drug conjugates for up to four...